Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
- PMID: 29844657
- PMCID: PMC5963830
- DOI: 10.2147/OPTH.S129645
Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
Abstract
Surgical management with enucleation was the primary treatment for uveal melanoma (UM) for over 100 years. The Collaborative Ocular Melanoma Study confirmed in 2001 that globe-preserving episcleral brachytherapy for UM was safe and effective, demonstrating no survival difference with enucleation. Today, brachytherapy is the most common form of radiotherapy for UM. We review the history of brachytherapy in the treatment of UM and the evolution of the procedure to incorporate fine-needle-aspiration biopsy techniques with DNA-and RNA-based genetic prognostic testing.
Keywords: UM; brachytherapy; fine-needle-aspiration biopsy; genetic prognostic testing; molecular markers; uveal melanoma.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Zakka KA, Foos RY, Omphroy CA, Straatsma BR. Malignant melanoma: analysis of an autopsy population. Ophthalmology. 1980;87(6):549–556. - PubMed
-
- Mooy CM, de Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41(3):215–228. - PubMed
-
- Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol. 1979;87(6):741–760. - PubMed
-
- Fraunfelder FT, Boozman FW, Wilson RS, Thomas AH. No-touch technique for intraocular malignant melanomas. Arch Ophthalmol. 1977;95(9):1616–1620. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources